CMDh News - December 2015
23.12.2015
more
23.12.2015
more
18.12.2015
more
18.12.2015
The European Medicines Agency (EMA) has issued new advice for doctors and patients on the potential risks related to the immunosuppressive effect of the multiple sclerosis medicine Gilenya (fingolimod).
more
04.12.2015
more
02.12.2015
Roche d.o.o., Stada d.o.o., Genera d.d., Novartis Hrvatska d.o.o. and Pliva Hrvatska d.o.o., in agreement with the Agency for Medicinal Products and Medical Devices of Croatia (HALMED) and the European Medicines Agency (EMA), have informed healthcare professionals about the strengthened advice for pregnancy prevention when using mycophenolic acid, which is also available in authorised medicinal products as pro-drug mycophenolate mofetil, as well as in the form of mycophenolate sodium.
more
02.12.2015
Laboratoire HRA Pharma, in agreement with the Agency for Medicinal Products and Medical Devices (HALMED) and the European Medicines Agency (EMA), has informed healthcare professionals about important safety information in relation to Ketoconazole HRA, authorised for the treatment of endogenous Cushing’s syndrome in adults and adolescents above 12 years.
more
26.11.2015
more
26.11.2015
Biogen Idec Ltd, in agreement with the Agency for Medicinal Products and Medical Devices of Croatia (HALMED) and the European Medicines Agency (EMA), has informed healthcare professionals of new important measures to minimise the risk of progressive multifocal leukoencephalopathy (PML) with Tecfidera.
more
20.11.2015
more
09.11.2015
more